Completed PHASE4 INTERVENTIONAL 2-arm NCT03361176

Kybella With Triamcinolone

A Randomized, Double-blind, Dose-ranging Trial of Subcutaneous Sodium Deoxycholate Injections With or Without Low Dose Triamcinolone and Low Dose Lidocaine for Reduction of Submental Fat With Reduction of Pain and Swelling

Sponsor: Allergan

Conditions Adiposity

Interventions Injectable sodium deoxycholate Injectable sodium deoxycholate with Triamcinolone acetate

Updated 7 times since 2017 Last updated: May 8, 2019 Started: Mar 26, 2018 Primary completion: Oct 12, 2018 Completion: Dec 18, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Adiposity and is currently completed. Allergan leads this study, which shows 7 recorded versions since 2018 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2019 — Jan 2021 [monthly]

Completed PHASE4

Status: Recruiting → Completed
Jun 2018 — Jun 2019 [monthly]

Recruiting PHASE4

▶ Show 2 earlier versions

Jan 2018 — Jun 2018 [monthly]

Recruiting PHASE4

Status: Not Yet Recruiting → Recruiting
Dec 2017 — Jan 2018 [monthly]

Not Yet Recruiting PHASE4

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Allergan
Goldman, Butterwick, Fitzpatrick and Groff
Maryland Laser Skin and Vein Institute

Data source: Goldman, Butterwick, Fitzpatrick and Groff

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Hunt Valley, United States
• San Diego, United States